Analysts See $-0.01 EPS for Archrock, Inc. (AROC); Medizone International (MZEI) Sentiment Is NaN

February 16, 2018 - By Linda Rogers

Medizone International Inc (MZEI) investors sentiment NaN in Q3 2017. It’s in 2017Q2. The ratio [12345], as 1 active investment managers started new or increased holdings, while 0 trimmed and sold holdings in Medizone International Inc. The active investment managers in our database now own: 1.53 million shares, down from 1.60 million shares in 2017Q2. Also, the number of active investment managers holding Medizone International Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 0 Increased: 0 New Position: 1.

Analysts expect Archrock, Inc. (NYSE:AROC) to report $-0.01 EPS on February, 22.They anticipate $0.05 EPS change or 83.33% from last quarter’s $-0.06 EPS. After having $-0.09 EPS previously, Archrock, Inc.’s analysts see -88.89% EPS growth. The stock decreased 1.59% or $0.15 during the last trading session, reaching $9.3. About 396,524 shares traded. Archrock, Inc. (NYSE:AROC) has risen 64.69% since February 16, 2017 and is uptrending. It has outperformed by 47.99% the S&P500.

Among 12 analysts covering Archrock (NYSE:AROC), 3 have Buy rating, 0 Sell and 9 Hold. Therefore 25% are positive. Archrock had 21 analyst reports since March 28, 2016 according to SRatingsIntel. Howard Weil upgraded the shares of AROC in report on Monday, March 28 to “Sector Perform” rating. Piperjaffray initiated the stock with “Neutral” rating in Monday, August 22 report. The rating was maintained by RBC Capital Markets on Monday, September 25 with “Buy”. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, August 5. The company was initiated on Monday, August 22 by PiperJaffray. On Monday, April 24 the stock rating was maintained by RBC Capital Markets with “Hold”. The rating was downgraded by RBC Capital Markets to “Underperform” on Tuesday, May 3. The stock has “Neutral” rating by Piper Jaffray on Monday, August 22. The stock of Archrock, Inc. (NYSE:AROC) has “Mkt Perform” rating given on Friday, July 15 by FBR Capital. RF Lafferty initiated it with “Buy” rating and $9.50 target in Tuesday, April 5 report.

Archrock, Inc. engages in the natural gas contract activities services business in the United States. The company has market cap of $660.04 million. The firm provides natural gas compression services to clients in the oil and natural gas industry. It currently has negative earnings. It also offers aftermarket services, such as parts and components; and operation, maintenance, overhaul, and reconfiguration services to clients who own compression equipment.

The stock decreased 1.08% or $0.0004 during the last trading session, reaching $0.0367. About shares traded. Medizone International, Inc. (MZEI) has 0.00% since February 16, 2017 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: